Cardiovascular Outcomes with Sotagliflozin
N Engl J Med
.
2021 Apr 15;384(15):1471.
doi: 10.1056/NEJMc2102961.
Authors
Lucien Marchand
1
,
Emmanuel Villar
1
,
Lisa Green
1
Affiliation
1
Centre Hospitalier Saint Joseph Saint Luc, Lyon, France lmarchand@ch-stjoseph-stluc-lyon.fr.
PMID:
33852787
DOI:
10.1056/NEJMc2102961
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetic Ketoacidosis*
Glycosides
Humans
Renal Insufficiency, Chronic*
Substances
Glycosides
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol